Dassault Systèmes takes a big step in the medical market. The company has completed its acquisition of Medidata Solutions worth 5.8 billion dollars (5.2 billion euros).
Dassault Systemès is a supplier of software for the digitisation of transport, aviation and life science companies. For example, the company creates 3D design tools to help organizations create virtual product designs, or to create digital simulations in product development.
The company’s portfolio is now complemented by Medidata Solutions, which creates software that allows clinics to manage their back-office operations and data. Medidata Solutions also produces analytics tools for clinics, enabling them to select large amounts of data.
Big step in the medical market
With the acquisition, which was announced in June this year, Dassault Systèmes is taking a step into the medical market. The company now claims to be able to lead the “digital transformation of life science” through a comprehensive solution.
“Medidata will be a core brand within our information intelligence domain,” said Bernard Charlès, Vice Chairman and CEO of Dassault Systemès. “By combining data intelligence and simulation, we deliver smarter therapies for healthier people.”
That’s necessary, because according to Dassault Systèmes, there’s a great transformation going on. Specifically, these are transformations that allow companies to deliver personalized experiences, rather than just products.
“Managing the complexity of personalized healthcare requires a digital platform that connects the points between people, ideas and data. The combination of Dassault Systemès and Medidata Solutions makes this connection possible,” says the company.
An important part of the portfolio will be the “inclusive and multi-disciplinary” 3DEXPERIENCE platform, says Charlès. This platform will be combined with Medidata solutions, which will enable life science companies to accelerate industrial performance, improve clinical trials and make drug development more efficient.
The platform also offers the option to tailor treatments to patients to deliver measurable results.